Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers

Impact of familial hypertrophic cardiomyopathy-linked mutations in the NH2 terminus of the RLC on β-myosin cross-bridge mechanics

(2014) Gerrie P. Farman et al.   JOURNAL OF APPLIED PHYSIOLOGY

Burden of Rare Sarcomere Gene Variants in the Framingham and Jackson Heart Study Cohorts

(2012) Alexander G. Bick et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Toronto Hypertrophic Cardiomyopathy Genotype Score for Prediction of a Positive Genotype in Hypertrophic Cardiomyopathy

(2012) Christiane Gruner et al.   Circulation-Cardiovascular Genetics

Genetic basis of end-stage hypertrophic cardiomyopathy

(2011) Pablo Garcia-Pavia et al.   EUROPEAN JOURNAL OF HEART FAILURE

Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands

(2011) I. Christiaans* et al.   Netherlands Heart Journal

Recurrent and founder mutations in the Netherlands: cardiac Troponin I (TNNI3) gene mutations as a cause of severe forms of hypertrophic and restrictive cardiomyopathy

(2011) A. van den Wijngaard et al.   Netherlands Heart Journal

Mutation Type Is Not Clinically Useful in Predicting Prognosis in Hypertrophic Cardiomyopathy

(2010) Andrew P. Landstrom et al.   CIRCULATION

Hypertrophic Cardiomyopathy

(2010) Carolyn Y. Ho   Heart Failure Clinics

The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers: focus on predictive screening

(2009) Imke Christiaans et al.   EUROPEAN HEART JOURNAL

Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives

(2008) Paal Skytt Andersen et al.   HUMAN MUTATION